| Year |
Citation |
Score |
| 2010 |
Tang G, Perng MD, Wilk S, Quinlan R, Goldman JE. Oligomers of mutant glial fibrillary acidic protein (GFAP) Inhibit the proteasome system in alexander disease astrocytes, and the small heat shock protein alphaB-crystallin reverses the inhibition. The Journal of Biological Chemistry. 285: 10527-37. PMID 20110364 DOI: 10.1074/Jbc.M109.067975 |
0.316 |
|
| 2006 |
Longenecker KL, Stewart KD, Madar DJ, Jakob CG, Fry EH, Wilk S, Lin CW, Ballaron SJ, Stashko MA, Lubben TH, Yong H, Pireh D, Pei Z, Basha F, Wiedeman PE, et al. Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors. Biochemistry. 45: 7474-82. PMID 16768443 DOI: 10.1021/Bi060184F |
0.343 |
|
| 2006 |
Dunys J, Kawarai T, Wilk S, St George-Hyslop P, Alves da Costa C, Checler F. Catabolism of endogenous and overexpressed APH1a and PEN2: evidence for artifactual involvement of the proteasome in the degradation of overexpressed proteins. The Biochemical Journal. 394: 501-9. PMID 16302845 DOI: 10.1042/Bj20051197 |
0.362 |
|
| 2006 |
Morty RE, Bulau P, Pellé R, Wilk S, Abe K. Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts. The Biochemical Journal. 394: 635-45. PMID 16248854 DOI: 10.1042/Bj20051593 |
0.31 |
|
| 2003 |
Petit A, Pasini A, Alves Da Costa C, Ayral E, Hernandez JF, Dumanchin-Njock C, Phiel CJ, Marambaud P, Wilk S, Farzan M, Fulcrand P, Martinez J, Andrau D, Checler F. JLK isocoumarin inhibitors: selective gamma-secretase inhibitors that do not interfere with notch pathway in vitro or in vivo. Journal of Neuroscience Research. 74: 370-7. PMID 14598313 DOI: 10.1002/Jnr.10747 |
0.354 |
|
| 2003 |
Orlowski M, Wilk S. Ubiquitin-independent proteolytic functions of the proteasome. Archives of Biochemistry and Biophysics. 415: 1-5. PMID 12801506 DOI: 10.1016/S0003-9861(03)00197-8 |
0.312 |
|
| 2002 |
Wilk S, Wilk E, Magnusson RP. Identification of histidine residues important in the catalysis and structure of aspartyl aminopeptidase. Archives of Biochemistry and Biophysics. 407: 176-83. PMID 12413488 DOI: 10.1016/S0003-9861(02)00494-0 |
0.315 |
|
| 2002 |
Pelegrini-da-Silva A, Prado WA, Juliano MA, Wilk S, Martins AR. High-performance liquid chromatographic separation of renin-angiotensin system peptides and most of their metabolic fragments. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 780: 301-7. PMID 12401356 DOI: 10.1016/S1570-0232(02)00542-1 |
0.337 |
|
| 2002 |
Marambaud P, Wilk S, Checler F. Protein Kinase A Phosphorylation of the Proteasome: A Contribution to the α‐Secretase Pathway in Human Cells Journal of Neurochemistry. 67: 2616-2619. PMID 8931498 DOI: 10.1046/J.1471-4159.1996.67062616.X |
0.313 |
|
| 2001 |
Wilk S, Chen W. Purification of the Eukaryotic 20S Proteasome Current Protocols in Protein Science. 25. PMID 18429167 DOI: 10.1002/0471140864.Ps2106S25 |
0.344 |
|
| 2000 |
Wilk S, Chen W, Magnusson RP. Properties of the Nuclear Proteasome Activator PA28γ (REGγ) Archives of Biochemistry and Biophysics. 383: 265-271. PMID 11185562 DOI: 10.1006/Abbi.2000.2086 |
0.348 |
|
| 2000 |
Wilk S, Chen W, Magnusson RP. Properties of the beta subunit of the proteasome activator PA28 (11S REG). Archives of Biochemistry and Biophysics. 384: 174-180. PMID 11147828 DOI: 10.1006/Abbi.2000.2112 |
0.333 |
|
| 2000 |
Orlowski M, Wilk S. Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex. Archives of Biochemistry and Biophysics. 383: 1-16. PMID 11097171 DOI: 10.1006/Abbi.2000.2036 |
0.356 |
|
| 2000 |
Ostrowska H, Wójcik C, Wilk S, Omura S, Kozlowski L, Stoklosa T, Worowski K, Radziwon P. Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/beta-lactone is not a specific inhibitor of the proteasome. The International Journal of Biochemistry & Cell Biology. 32: 747-57. PMID 10856705 DOI: 10.1016/S1357-2725(00)00021-2 |
0.394 |
|
| 1999 |
Wilk S, Chen W, Magnusson RP. Modulators of the activation of the proteasome by PA28 (11S reg). Molecular Biology Reports. 26: 39-44. PMID 10363645 DOI: 10.1023/A:1006955904443 |
0.364 |
|
| 1999 |
Wójcik C, Wilk S. Changes in proteasome expression and activity during differentiation of neuronal precursor NTera 2 clone D1 cells. Neurochemistry International. 34: 131-136. PMID 10213071 DOI: 10.1016/S0197-0186(98)00079-5 |
0.325 |
|
| 1999 |
Barelli H, Petit A, Hirsch E, Wilk S, Nanteuil GD, Morain P, Checler F. S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase. Biochemical and Biophysical Research Communications. 257: 657-661. PMID 10208839 DOI: 10.1006/Bbrc.1999.0366 |
0.357 |
|
| 1999 |
Wilk S, Chen W, Magnusson RP. Modulation of the PA28α–20S Proteasome Interaction by a Peptidyl Alcohol☆☆☆ Archives of Biochemistry and Biophysics. 362: 283-290. PMID 9989937 DOI: 10.1006/Abbi.1998.1034 |
0.307 |
|
| 1999 |
Shane R, Wilk S, Bodnar RJ. Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV. Brain Research. 815: 278-86. PMID 9878785 DOI: 10.1016/S0006-8993(98)01121-4 |
0.324 |
|
| 1998 |
Wójcik C, Tanaka K, Paweletz N, Naab U, Wilk S. Proteasome activator (PA28) subunits, α, β and γ (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells European Journal of Cell Biology. 77: 151-160. PMID 9840465 DOI: 10.1016/S0171-9335(98)80083-6 |
0.322 |
|
| 1998 |
Wilk S, Chen W, Magnusson RP. Properties of the Proteasome Activator Subunit PA28α and its Des-Tyrosyl Analog Archives of Biochemistry and Biophysics. 359: 283-290. PMID 9808770 DOI: 10.1006/Abbi.1998.0918 |
0.341 |
|
| 1998 |
Vazeux G, Wilk S, Wilk E, Corvol P, Llorens‐Cortès C. Production and properties of a recombinant soluble form of aminopeptidase A Febs Journal. 254: 671-678. PMID 9688281 DOI: 10.1046/J.1432-1327.1998.2540671.X |
0.31 |
|
| 1998 |
Wilk S, Wilk E, Magnusson RP. Purification, Characterization, and Cloning of a Cytosolic Aspartyl Aminopeptidase Journal of Biological Chemistry. 273: 15961-15970. PMID 9632644 DOI: 10.1074/Jbc.273.26.15961 |
0.34 |
|
| 1997 |
Marambaud P, Rieunier F, Wilk S, Martinez J, Checler F. Contribution of the proteasome to the alpha-secretase pathway in Alzheimer's disease. Advances in Experimental Medicine and Biology. 421: 267-272. PMID 9330707 DOI: 10.1007/978-1-4757-9613-1_35 |
0.319 |
|
| 1997 |
Wilk S, Chen W. Synthetic peptide-based activators of the proteasome Molecular Biology Reports. 24: 119-124. PMID 9228292 DOI: 10.1023/A:1006851428691 |
0.332 |
|
| 1995 |
Figueiredo-Pereira ME, Chen WE, Yuan HM, Wilk S. A novel chymotrypsin-like component of the multicatalytic proteinase complex optimally active at acidic pH. Archives of Biochemistry and Biophysics. 317: 69-78. PMID 7872805 DOI: 10.1006/abbi.1995.1137 |
0.649 |
|
| 1995 |
Wilk S, Figueiredo-Pereira ME. Synthetic inhibitors of the multicatalytic proteinase complex (proteasome). Enzyme & Protein. 47: 306-13. PMID 7697128 DOI: 10.1159/000468688 |
0.629 |
|
| 1994 |
Figueiredo-Pereira ME, Banik N, Wilk S. Comparison of the effect of calpain inhibitors on two extralysosomal proteinases: The multicatalytic proteinase complex and m-calpain Journal of Neurochemistry. 62: 1989-1994. PMID 8158145 DOI: 10.1046/J.1471-4159.1994.62051989.X |
0.668 |
|
| 1994 |
Figueiredo-Pereira ME, Berg KA, Wilk S. A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell Journal of Neurochemistry. 63: 1578-1581. PMID 7931314 DOI: 10.1046/J.1471-4159.1994.63041578.X |
0.658 |
|
| 1994 |
Chauvel EN, Llorens-Cortes C, Coric P, Wilk S, Roques BP, Fournie-Zaluski M. Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols. Journal of Medicinal Chemistry. 37: 2950-2957. PMID 7915326 DOI: 10.1021/Jm00044A016 |
0.37 |
|
| 1994 |
Chauvel EN, Coric P, Llorens-Cortes C, Wilk S, Roques BP, Fournie-Zaluski M. Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors. Journal of Medicinal Chemistry. 37: 1339-1346. PMID 7909847 DOI: 10.1021/Jm00035A014 |
0.375 |
|
| 1992 |
Pereira ME, Yu B, Wilk S. Enzymatic changes of the bovine pituitary multicatalytic proteinase complex, induced by magnesium ions Archives of Biochemistry and Biophysics. 294: 1-8. PMID 1550335 DOI: 10.1016/0003-9861(92)90128-J |
0.363 |
|
| 1991 |
Suen C, Wilk S. Inhibition of pyroglutamyl peptidase II synthesis by phorbol ester in the Y-79 retinoblastoma cell. Endocrinology. 128: 2169-2174. PMID 1672274 DOI: 10.1210/Endo-128-4-2169 |
0.332 |
|
| 1990 |
Pereira ME, Wilk S. Phosphorylation of the multicatalytic proteinase complex from bovine pituitaries by a copurifying cAMP-dependent protein kinase. Archives of Biochemistry and Biophysics. 283: 68-74. PMID 2173492 DOI: 10.1016/0003-9861(90)90613-4 |
0.348 |
|
| 1990 |
Mendez M, Cruz C, Joseph-Bravo P, Wilk S, Charli JL. Evaluation of the role of prolyl endopeptidase and pyroglutamyl peptidase I in the metabolism of LHRH and TRH in brain. Neuropeptides. 17: 55-62. PMID 1980725 DOI: 10.1016/0143-4179(90)90050-9 |
0.355 |
|
| 1990 |
Suen C, Wilk S. Rapid Inactivation and Phosphorylation of Pyroglutamyl Peptidase II in Y-79 Human Retinoblastoma Cells after Exposure to Phorbol Ester* Endocrinology. 127: 3038-3046. PMID 1979029 DOI: 10.1210/Endo-127-6-3038 |
0.35 |
|
| 1989 |
Suen C, Wilk S. Sodium Butyrate Induces Pyroglutamyl Peptidase I and Decreases Thyrotropin-Releasing Hormone Receptors in GH3 Cells* Endocrinology. 124: 1654-1660. PMID 2564336 DOI: 10.1210/Endo-124-4-1654 |
0.303 |
|
| 1988 |
Wilk S, Suen C, Wilk EK. Occurrence of pyroglutamyl peptidase II, a specific TRH degrading enzyme in rabbit retinal membranes and in human retinoblastoma cells Neuropeptides. 12: 43-47. PMID 2901687 DOI: 10.1016/S0143-4179(98)90009-9 |
0.311 |
|
| 1987 |
Bier MJ, Goldfarb J, Orlowski M, Wilk S. Intracerebroventricular infusion of inhibitors of endopeptidase-24.11 (‘enkephalinase’) increases the spontaneous firing frequency of an identifiable set of cells in the substantia nigra European Journal of Pharmacology. 142: 321-330. PMID 3480807 DOI: 10.1016/0014-2999(87)90070-7 |
0.35 |
|
| 1987 |
Charli JL, Mendez M, Joseph-Bravo P, Wilk S. Specific inhibitors of pyroglutamyl peptidase I and prolyl endopeptidase do not change the in vitro release of TRH or its content in rodent brain. Neuropeptides. 9: 373-8. PMID 2886950 DOI: 10.1016/0143-4179(87)90010-2 |
0.306 |
|
| 1986 |
Friedman TC, Davies TF, Wilk S. Evidence for regulation of a thyrotropin-releasing hormone degradation pathway in GH3 cells. Endocrinology. 118: 562-566. PMID 3080309 DOI: 10.1210/Endo-118-2-562 |
0.386 |
|
| 1985 |
Friedman TC, Kline TB, Wilk S. 5-Oxoprolinal: transition-state aldehyde inhibitor of pyroglutamyl-peptide hydrolase Biochemistry. 24: 3907-3913. PMID 2864952 DOI: 10.1021/Bi00336A015 |
0.344 |
|
| 1984 |
Murthy LR, Glick SD, Almenoff J, Wilk S, Orlowski M. Inhibitors of an enkephalin degrading membrane-bound metalloendopeptidase: Analgesic properties and effects on striatal enkephalin levels European Journal of Pharmacology. 102: 305-313. PMID 6383843 DOI: 10.1016/0014-2999(84)90262-0 |
0.334 |
|
| 1982 |
Dresdner K, Barker LA, Orlowski M, Wilk S. Subcellular distribution of prolyl endopeptidase and cation-sensitive neutral endopeptidase in rabbit brain. Journal of Neurochemistry. 38: 1151-1154. PMID 7038048 DOI: 10.1111/J.1471-4159.1982.Tb05362.X |
0.314 |
|
| 1982 |
Wilk S, Orlowski M. Determination of specificity of endopeptidases by combined high-performance liquid chromatography and amino acid analysis. Journal of Chromatography A. 249: 121-129. PMID 6757262 DOI: 10.1016/S0021-9673(00)80238-1 |
0.335 |
|
| 1981 |
Orlowski M, Wilk S. Purification and specificity of a membrane-bound metalloendopeptidase from bovine pituitaries. Biochemistry. 20: 4942-4950. PMID 7028098 DOI: 10.1021/Bi00520A021 |
0.318 |
|
| 1979 |
Wilk S, Orlowski M. Degradation of bradykinin by isolated neutral endopeptidases of brain and pituitary. Biochemical and Biophysical Research Communications. 90: 1-6. PMID 496963 DOI: 10.1016/0006-291X(79)91581-X |
0.323 |
|
| 1971 |
Gitlow SE, Mendlowitz M, Bertani LM, Wilk S, Wilkek. Human norepinephrine metabolism. Its evaluation bydministration of tritiated norepinephrine. The Journal of Clinical Investigation. 50: 859-65. PMID 5547279 DOI: 10.1172/Jci106557 |
0.593 |
|
| 1968 |
Gitlow SE, Mendlowitz M, Wilk EK, Wilk S, Wolf RL, Bertani LM. Excretion of catecholamine catabolites by normal children The Journal of Laboratory and Clinical Medicine. 72: 612-620. PMID 4300305 DOI: 10.5555/Uri:Pii:0022214368901881 |
0.569 |
|
| 1967 |
Wilk S, Gitlow SE, Clarke DD, Paley DH. Determination of urinary 3-methoxy-4-hydroxyphenyl-ethylene glycol by gas-liquid chromatography and electron capture detection. Clinica Chimica Acta; International Journal of Clinical Chemistry. 16: 403-8. PMID 6035186 DOI: 10.1016/0009-8981(67)90306-3 |
0.587 |
|
| 1965 |
Wilk S, Gitlow SE, Mendlowitz M, Franklin MJ, Carr HE, Clarke DD. A quantitative assay for vanillylmandelic acid (VMA) by gas-liquid chromatography. Analytical Biochemistry. 13: 544-51. PMID 5881310 DOI: 10.1016/0003-2697(65)90349-0 |
0.58 |
|
| 1964 |
GITLOW SE, MENDLOWITZ M, WILK EK, WILK S, WOLF RL, NAFTCHI NE. PLASMA CLEARANCE OF DL-BETA-H3-NOREPINEPHRINE IN NORMAL HUMAN SUBJECTS AND PATIENTS WITH ESSENTIAL HYPERTENSION The Journal of Clinical Investigation. 43: 2009-2015. PMID 14236225 DOI: 10.1172/Jci105075 |
0.559 |
|
| 1964 |
WILK S, GITLOW SE, FRANKLIN MJ, CARR HE. A MICOQUANTITATIVE TECHNIQUE FOR THE DETECTION OF SOME BIOLOGICALLY IMPORTANT AMINES BY GAS-LIQUID CHROMATOGRAPHY. Clinica Chimica Acta; International Journal of Clinical Chemistry. 10: 193-5. PMID 14205559 DOI: 10.1016/0009-8981(64)90166-4 |
0.531 |
|
| 1963 |
GITLOW SE, MENDLOWITZ M, WILK EK, WILK S, WOLF RL. THE DIAGNOSIS OF PHEOCHROMOCYTOMA Proceedings of the Rudolf Virchow Medical Society in the City of New. 22: 43-45. PMID 14277743 DOI: 10.1159/000428932 |
0.529 |
|
| Show low-probability matches. |
